Chicago, IL – May 1, 2023 – Today, Zacks Investment Ideas feature highlights Novo Nordisk NVO and Clearfield CLFD.
A Simple System to Identify Winning Stocks in Volatile Markets
The stock market can seem complicated and confusing at times, even to seasoned investors. Individual stocks can move up or down seemingly without reason. Your favorite company reports terrible earnings but the stock surges. The price of oil drops and economic data comes in better-than-expected, but the major indices nosedive. Often, the market’s reaction to the news is much more important than the news itself.
In the stock market, we don’t necessarily need to know why something is happening – we just need to know that it’s happening. Financial analysts are paid to decipher company fundamentals in an effort to produce buy and sell ratings on stocks. But how many times have you seen a stock with poor fundamentals soar, while one with superb fundamentals plunges?
For the average investor, following a system rather than relying on predictions is going to produce much more favorable results over time. We don’t necessarily need to know exactly why a stock is moving in a certain direction, we just need to know which way it’s most likely to go.
Let’s take a look at a simple example. We want to target stocks whose buying pressure is exceeding any selling pressure, and avoid stocks that are experiencing heavy selling. Moving averages are a great way to ‘smooth’ out the price trend for a given stock. In our example, we’ll stick with the simple 50-day moving average as our guide in conjunction with the Zacks Rank system, which harnesses the power of positive earnings estimate revisions.
Below we see a 6-month chart of Novo Nordisk, a Zacks Rank #1 (Strong Buy). Notice that NVO is in an uptrend and how the stock is trading above the 50-day moving average (blue line). The 50-day moving average has acted as support throughout the powerful upside move. NVO has soared more than 57% over the past six months.
Novo Nordisk is a health care company that is engaged in the research, development, and marketing of pharmaceutical products. The company focuses on manufacturing products for diabetes, obesity, and rare diseases.
NVO stock has been making a series of 52-week highs and is experiencing positive earnings estimate revisions. Analysts are in agreement and have been raising EPS estimates across the board. For the current year, estimates have increased 7.31% in the past 60 days. The 2023 Zacks Consensus Estimate now stands at $4.70/share, reflecting potential growth of 35.84% relative to last year.
Now let’s examine a stock whose selling pressure is exceeding its buying pressure. Below we can see a year-to-date chart of Clearfield, a Zacks Rank #5 (Strong Sell). Notice that CLFD is in a downtrend and how the 50-day moving average has been steadily falling. 2023 has not been kind to CLFD, as the stock has lost more than half its value. The 50-day moving average is sloping down and CLFD is making a series of 52-week lows.
Clearfield designs and manufactures passive connectivity products, such as its FieldSmart fiber management platform. Its fiber-based products support a wide range of panel configurations and densities and are utilized by exchange carriers, wireless operators, cable TV companies, and data center markets.
CLFD is also witnessing negative earnings estimate revisions. Analysts are in agreement and have decreased estimates across the board. For the first quarter, estimates have been slashed by -8.33% in the past 60 days. The Q1 Zacks Consensus Estimate now stands at $0.55/share, translating to negative growth of -16.67% relative to the same quarter in the prior year.
We can see the power behind following a system and how it can help us both locate winning stocks and avoid losing ones. The next time you want to buy a stock, use the Zacks Rank to ensure the company is witnessing positive earnings estimate revisions. Incorporating simple technical analysis using moving averages is another great way to narrow down the playing field.
Why Haven’t You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
